Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Precision Therapeutics Inc (AIPT)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 13,534
  • Shares Outstanding, K 13,400
  • Annual Sales, $ 650 K
  • Annual Income, $ -7,750 K
  • 36-Month Beta 1.09
  • Price/Sales 20.45
  • Price/Cash Flow N/A
  • Price/Book 3.51

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.98 +4.08%
on 09/19/18
1.24 -17.74%
on 08/31/18
-0.13 (-11.30%)
since 08/21/18
3-Month
0.98 +4.08%
on 09/19/18
1.58 -35.44%
on 07/13/18
-0.06 (-5.56%)
since 06/21/18
52-Week
0.81 +25.93%
on 04/04/18
2.50 -59.20%
on 11/01/17
-0.38 (-27.14%)
since 09/21/17

Most Recent Stories

More News
Precision Therapeutics Bolsters Scientific Advisory Board with the Appointment of Dr. Paul Kornblith

Precision Therapeutics Inc. (NASDAQ: AIPT) ("Precision" or "the Company"), a company focused on applying artificial intelligence to personalized medicine and drug discovery, has bolstered its Scientific...

AIPT : 1.02 (+0.99%)
Precision Therapeutics Appoints Dr. Amelia Warner to Scientific Advisory Board

Precision Therapeutics Inc. (NASDAQ:AIPT) ("Precision" or "the Company"), a company focused on applying artificial intelligence to personalized medicine and drug discovery, is pleased to announce that...

AIPT : 1.02 (+0.99%)
MRK : 71.25 (+0.66%)
Precision Therapeutics Investee, Helomics Corporation, Announces Commercial Launch of New 'HelomicsDiscover' Program to Drive Forward the Next Generation of Precision Cancer Therapies

Precision Therapeutics Inc. (NASDAQ: AIPT) ("Precision" or "the Company"), a company focused on applying artificial intelligence to personalized medicine and drug discovery, is pleased to announce that...

AIPT : 1.02 (+0.99%)
Precision Therapeutics Investee, Helomics Corporation, Launches Precision Oncology Insights Platform

Precision Therapeutics Inc. (NASDAQ: AIPT) ("Precision" or "the Company"), a company focused on applying artificial intelligence to personalized medicine and drug discovery, is pleased to announce that...

AIPT : 1.02 (+0.99%)
Precision Therapeutics Making Rapid Progress with Both Personalized Medicine and Unique Medical Waste Disposal System

EQNX::TICKER_START (Nasdaq:AIPT), EQNX::TICKER_END

AIPT : 1.02 (+0.99%)
Precision Therapeutics Receives Approval of Delisting Request from German Stock Exchange

Precision Therapeutics Inc. (NASDAQ: AIPT) ("Precision" or "the Company"), a company focused on applying artificial intelligence to personalized medicine and drug discovery, has received confirmation from...

AIPT : 1.02 (+0.99%)
Precision Therapeutics Merger with Helomics Corp. Accelerates Personalized Cancer Treatment Strategies

In an Interview with CEOCFO Magazine, CEO Dr. Carl Schwartz Explains how the Company's Database of Tumors, Artificial Intelligence Technology, and Groundbreaking Method for Growing Human Cancer Cells Makes...

AIPT : 1.02 (+0.99%)
Precision Therapeutics Signs Definitive Merger Agreement with Helomics Holding Corporation

Precision Therapeutics Inc. (NASDAQ:AIPT) ("Precision" or "the Company"), a company focused on applying artificial intelligence to personalized medicine and drug discovery, is pleased to announce that...

AIPT : 1.02 (+0.99%)
Precision Therapeutics Reports First Quarter 2018 Financial Results

Precision Therapeutics Inc. (NASDAQ:AIPT) ("Precision" or "the Company"), a company focused on applying artificial intelligence to personalized medicine and drug discovery, announced today financial results...

AIPT : 1.02 (+0.99%)
Precision Therapeutics Projects Meaningful STREAMWAY System Sales in Europe in the Second Half of 2018

Precision Therapeutics Inc. (NASDAQ:AIPT) ("Precision" or "the Company"), a company focused on applying artificial intelligence to personalized medicine and drug discovery and producer of the FDA-approved...

AIPT : 1.02 (+0.99%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Sell with a Weakening short term outlook on maintaining the current direction.

Longer term, the trend strength is Average. Long term indicators mostly agree with the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Trade AIPT with:

Business Summary

Precision Therapeutics Inc. operating business areas includes development of a healthcare CRO which provides personalized medicine solutions for clients in the pharmaceutical, diagnostic and biotech industries as well as production of the FDA-approved STREAMWAY(R) System for automated, direct-to-drain...

See More

Key Turning Points

2nd Resistance Point 1.06
1st Resistance Point 1.03
Last Price 1.02
1st Support Level 0.99
2nd Support Level 0.98

See More

52-Week High 2.50
Fibonacci 61.8% 1.85
Fibonacci 50% 1.65
Fibonacci 38.2% 1.46
Last Price 1.02
52-Week Low 0.81

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar